Prasco Laboratories Inc., the Mason generic drug manufacturer, said Monday it has agreed to supply a generic version of an antibacterial treatment for urinary tract infections.
Under the terms of the agreement, Prasco will market and distribute Nitrofurantoin Oral Suspension, the authorized generic version of Furadantin Oral Suspension sold by Shionogi Inc. Prasco intends to begin shipping product immediately in the United States under the Prasco label.
Prasco Chief Executive Officer E. Thomas Arington said “this agreement expands our relationship with Shionogi, a leading global pharmaceutical company.”
The two companies signed a similar agreement earlier this year.
Prasco said it has now brought 33 authorized generics to market, more than any other company. Authorized generics are identical to branded products. Established brand companies work with Prasco to bring their brands to the generic market as authorized generics, offering alternatives to consumers and pharmacists.
